Fig. 2From: Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort studyComparison of cumulative incidence for renal outcomes according to the baseline cardiocerebrovascular disease (CVD)Back to article page